Get the Stockscreener App
2.115
3.86%
-0.085
After Hours:
2.12
0.005
+0.24%
Cytomed Therapeutics Ltd stock is traded at $2.115, with a volume of 14,340.
It is down -3.86% in the last 24 hours and up +5.22% over the past month.
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
See More
Previous Close:
$2.20
Open:
$2.16
24h Volume:
14,340
Relative Volume:
0.20
Market Cap:
$25.81M
Revenue:
-
Net Income/Loss:
$-3.15M
P/E Ratio:
-6.9299
EPS:
-0.3052
Net Cash Flow:
$-2.23M
1W Performance:
-12.60%
1M Performance:
+5.22%
6M Performance:
-8.84%
1Y Performance:
-8.24%
1-Day Range:
$2.09
$2.17
1-Week Range:
$2.09
$2.45
52-Week Range:
$1.65
$4.0499
Cytomed Therapeutics Ltd Stock (GDTC) Company Profile
Name
Cytomed Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare GDTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDTC
Cytomed Therapeutics Ltd
|
2.115 | 25.81M | 0 | -3.15M | -2.23M | -0.3052 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cytomed Therapeutics Ltd Stock (GDTC) Latest News
Can CytoMed Therapeutics Limited stock deliver surprise earnings beatJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
CytoMed Therapeutics Limited stock trend outlook and recovery path2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com
CytoMed Therapeutics Limited recovery potential after sell offGap Up & Weekly Return Optimization Plans - newser.com
Is a relief rally coming for CytoMed Therapeutics Limited holdersTrade Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
Will CytoMed Therapeutics Limited stock split attract more investorsMarket Sentiment Report & Growth Focused Stock Reports - newser.com
What earnings revisions data tells us about CytoMed Therapeutics Limited2025 Volume Leaders & Intraday High Probability Setup Alerts - newser.com
Chart based analysis of CytoMed Therapeutics Limited trendsDividend Hike & Long-Term Growth Plans - newser.com
Can CytoMed Therapeutics Limited (F98) stock sustain double digit ROEJuly 2025 Volume & Daily Entry Point Alerts - newser.com
Using fundamentals and technicals on CytoMed Therapeutics LimitedSell Signal & Technical Pattern Recognition Alerts - newser.com
What MACD and RSI say about CytoMed Therapeutics Limited2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
CytoMed Therapeutics Limited stock outlook for YEARWeekly Investment Report & Community Trade Idea Sharing - newser.com
Will CytoMed Therapeutics Limited (F98) stock keep high P E multiplesJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
How CytoMed Therapeutics Limited (F98) stock responds to bond marketCEO Change & Long-Term Safe Investment Plans - newser.com
Should you wait for a breakout in CytoMed Therapeutics Limited2025 Risk Factors & Expert Approved Momentum Ideas - newser.com
Why CytoMed Therapeutics Limited stock appeals to dividend seekersJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Long term hold vs stop loss in CytoMed Therapeutics Limited2025 Price Targets & High Accuracy Trade Alerts - newser.com
Why CytoMed Therapeutics Limited stock could benefit from AI revolution2025 Valuation Update & Long Hold Capital Preservation Tips - newser.com
Published on: 2025-10-25 16:06:34 - newser.com
What does recent volatility data suggest for CytoMed Therapeutics Limited2025 Volume Leaders & Fast Entry Momentum Alerts - newser.com
What recovery options are there for CytoMed Therapeutics LimitedEarnings Summary Report & Free Real-Time Market Sentiment Alerts - newser.com
What insider purchases suggest about CytoMed Therapeutics Limited (F98) stockJuly 2025 Momentum & Weekly Market Pulse Alerts - newser.com
Can you recover from losses in CytoMed Therapeutics Limited2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
Heatmap analysis for CytoMed Therapeutics Limited and competitorsPortfolio Update Report & Precise Buy Zone Identification - newser.com
Can CytoMed Therapeutics Limited recover in the next quarter2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Cytomed Therapeutics Ltd Stock (GDTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):